"This new building is yet another example of how the bioscience innovation process continues to thrive on this campus. It's a virtuous cycle," said CU Anschutz Chancellor Don Elliman. "We're providing a clear path for our faculty to take ideas into the commercial realm, which enables us to attract top talent, who generate further innovation -- all for the ultimate benefit of the health of people in Colorado and beyond."
Dr. Huntington Potter, Professor of Neurology at the University of Colorado School of Medicine says that scientists all over the world are trying to understand the mechanism of Alzheimer’s and to use that information to develop new drugs.
They're testing the world's first biodegradable balloon you can swallow to lose weight. It's a less invasive alternative to gastric bypass surgery. Associate professor of gastroenterology at the CU School of Medicine Dr. Shelby Sullivan is leading the trial in Colorado.
A new vaccine that does a better job of preventing shingles was developed by researchers at the University of Colorado Anschutz Medical Campus. The Food and Drug Administration approved the new vaccine -- called Shingrix -- last week and the Centers for Disease Control’s Advisory Committee on Immunization Practices recommended it for patients 50 and older this week. The committee also recommended using Shingrix instead of the currently-available vaccine Zostavax.
According to a recent survey from the University of Colorado Anschutz Medical Campus, you could take that firearm to a nearby law enforcement agency or gun store and chances are, they’d be willing to hold it temporarily. Epidemiology professor Carol Runyan and her colleagues at the Colorado School of Public Health at CU Anschutz contacted hundreds of law enforcement agencies and gun retailers in Colorado, Arizona, Idaho, Montana, Nevada, New Mexico, Utah and Wyoming to gauge their willingness to store guns in a crisis situation.
"An altruistic donor can spike a big chain reaction," said Dr. Monica Grafales with the University of Colorado's Live Donor program, who said altruistic, or angel, donors are rare and badly needed. "The majority of people we put in the kidney transplant waitlist, many of them die while waiting, because there are just not enough donors. "
"Australia, where most of the data has been validated, they saw two and a half more flu cases this year than they did last year," said CU professor Michelle Barron. Barron has been researching the virus for over a decade. Vaccines and medications have come a long way over the years, but what can help you is a flu shot.
